Atlas Trials

Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer

Clinical trial NCT00080080 · COMPLETED

Trial details

NCT number
NCT00080080
Sponsor
Point Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.